Inspire Sleep Apnea Surgical Treatment

Struggling with CPAP? Advantage ENT is proud to offer Inspire therapy.

What Is Inspire® Therapy?

Inspire therapy is a mask-free1 solution for people with obstructive sleep apnea (OSA) who have tried and struggled with CPAP. Through a simple-to-use system that includes the Inspire® implant, Inspire™ remote, and Inspire® app, Inspire therapy enables you to control your OSA treatment from the palm of your hand.

How Does Inspire Therapy Work?

During sleep, your tongue relaxes. In people with OSA, the tongue relaxes into a position that blocks the airway. While other OSA therapies use a hose and mask to force air through your airway, the Inspire implant works comfortably2 inside your body to sense when you breathe. Then, it delivers gentle pulses that move your tongue forward to keep your airway open, helping you breathe regularly and sleep soundly. Simply use the small handheld Inspire® remote to turn your therapy on when you’re ready to sleep.

The Inspire implant keeps your airway open while you sleep, so you can breathe regularly and sleep soundly.

The handheld Inspire remote simply turns on your therapy when you’re ready to sleep. No mask or hose required.

The Inspire app tracks your sleep goals and allows you to share data directly with your doctor.

Is Inspire Therapy Right for You?

To be a candidate for Inspire therapy, you must meet the following FDA indications:

  • Age 18 or older
  • Diagnosed with moderate to severe OSA
  • Have tried and struggled with CPAP

To learn more about Inspire and connect with patient ambassadors, visit InspireSleep.com.

Meet Your Provider, Dr. Kate Wallerius

To Get Started, Schedule a Visit

The first step is to schedule a consultation with our team. We’ll discuss your current therapy, provide details on Inspire therapy and answer your questions.

1. ADHERE Registry: Data on File
2. Suurna MV, Steffen A, Boon M, et al. Impact of Body Mass Index and Discomfort on Upper Airway Stimulation: ADHERE Registry 2020 Update. Laryngoscope 2021; 131(11): 2616-2624